Pulmonology

  • In Reply: COVID-19 coagulopathy
    Simon R. Mucha, MD, Siddharth Dugar, MD, Keith McCrae, MD, Douglas Joseph, DO, John Bartholomew, MD, Gretchen L. Sacha, PharmD, RPh, BCCCP and Michael Militello, PharmD, RPh, BCPS
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 712; DOI: https://doi.org/10.3949/cjm.87c.12002

    An attempt to balance the potential risks and benefits of intensified prophylaxis.

  • COVID-19 coagulopathy
    Anup Katyal, MD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 712; DOI: https://doi.org/10.3949/ccjm.87c.12001

    Skepticism of high-intensity prophylaxis for patients with D-dimer ≥ 3.0 µg/mL.

  • Dexamethasone or hydrocortisone in COVID-19?
    Chia Siang Kow and Syed Shahzad Hasan
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 715; DOI: https://doi.org/10.3949/ccjm.87c.12005

    Dexamethasone should be favored over hydrocortisone.

  • Is regular oxygen supplementation safe for obese postoperative patients?
    Roop Kaw, MD and Anthony G. Doufas, MD, PhD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 723-727; DOI: https://doi.org/10.3949/ccjm.87a.19051

    Caution for some, but no evidence to support withholding it altogether.

  • Fever in a lung transplant recipient
    Graham Walter, MD, Hanna Lyubetska, MD, MSc and Aditya Sharma, MD, FRCPC
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 735-741; DOI: https://doi.org/10.3949/ccjm.87a.19132

    A 36-year-old woman presents with high fevers, chills, nausea, decreased oral intake, and diarrhea.

  • Long-term consequences of prematurity
    Cristina I. Pravia, MD and Merline Benny, MD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 759-767; DOI: https://doi.org/10.3949/ccjm.87a.19108

    Survivors of premature birth may have adverse health effects later in life.

  • COVID-19 and flu: Dual threat, dual opportunity
    Sherif Beniameen Mossad, MD, FACP, FIDSA, FAST
    Cleveland Clinic Journal of Medicine November 2020, 87 (11) 651-655; DOI: https://doi.org/10.3949/ccjm.87a.20161

    Measures to combat COVID-19 can minimize the impact of flu, and vice versa.

  • Does my healthy 65-year-old patient still need the 13-valent pneumococcal conjugate vaccine (PCV13)?
    Craig D. Nielsen, MD, FACP and Xian Wen Jin, MD, PhD, FACP
    Cleveland Clinic Journal of Medicine November 2020, 87 (11) 656-658; DOI: https://doi.org/10.3949/ccjm.87a.20012

    The short answer is no—but it is not that simple.

  • Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19
    Chao-Ping Wu, MD, Fatima Adhi, MD and Kristin Highland, MD
    Cleveland Clinic Journal of Medicine November 2020, 87 (11) 659-663; DOI: https://doi.org/10.3949/ccjm.87a.ccc015

    Consider the presentation and trajectory of illness.

  • Convalescent plasma for COVID-19: Promising, not proven
    Simon R. Mucha, MD and NurJehan Quraishy, MD
    Cleveland Clinic Journal of Medicine November 2020, 87 (11) 664-670; DOI: https://doi.org/10.3949/ccjm.87a.ccc056

    The evidence is suggestive but weak. Trials are ongoing.

Pages